Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Investigational New Drugs|November 11, 1992
Phase II study of gemcitabine in advanced colorectal adenocarcinomaD F Moore, R Pazdur, K Daugherty, et al.
Investigational New Drugs|January 1, 1997
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day scheduleR Pazdur, Y Lassere, E Diaz-Canton, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancerP M Hoff, E D Saad, N Janjan, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
Investigational New Drugs|May 1, 1991
Working conference on biomodulator and chemotherapy combination therapiesT D Brown, M S Mitchell, R Pazdur, et al.
Clinical Pharmacology and Therapeutics|August 9, 2014
Optimizing dosing of oncology drugsL Minasian, O Rosen, D Auclair, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Preoperative UFT and calcium folinate and radiotherapy in rectal cancerP M Hoff, Y Lassere, R Pazdur, et al.
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Investigational New Drugs|November 11, 1992
Phase II study of gemcitabine in advanced colorectal adenocarcinomaD F Moore, R Pazdur, K Daugherty, et al.
Investigational New Drugs|January 1, 1997
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day scheduleR Pazdur, Y Lassere, E Diaz-Canton, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancerP M Hoff, E D Saad, N Janjan, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
Investigational New Drugs|May 1, 1991
Working conference on biomodulator and chemotherapy combination therapiesT D Brown, M S Mitchell, R Pazdur, et al.
Clinical Pharmacology and Therapeutics|August 9, 2014
Optimizing dosing of oncology drugsL Minasian, O Rosen, D Auclair, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Preoperative UFT and calcium folinate and radiotherapy in rectal cancerP M Hoff, Y Lassere, R Pazdur, et al.
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Pageof 16